Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine. - Institut Pasteur Access content directly
Journal Articles Vaccine Year : 2007

Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine.

Abstract

Human immunodeficiency virus (HIV-1) and hepatitis B virus (HBV) spread via similar transmission pathways, and infection by HBV occurs in up to 32% of HIV-1 cases. Here, we describe the successful expression of novel recombinant HIV-1/HBV virus-like particles (VLPs) in Nicotiana tabacum and Arabidopsis thaliana. The production levels and quality of the recombinant VLPs were comparable in the two plants, showing that parameters intrinsic to the recombinant proteins determined their assembly into VLPs. These heterologous VLPs can be used in a bivalent anti-HIV-1/-HBV vaccine, administrated via ingestion of transgenic plants.

Dates and versions

pasteur-00363393 , version 1 (23-02-2009)

Identifiers

Cite

Raffaella Greco, Marie Michel, Denise Guetard, Minerva Cervantes-Gonzalez, Nilla Pelucchi, et al.. Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine.. Vaccine, 2007, 25 (49), pp.8228-40. ⟨10.1016/j.vaccine.2007.09.061⟩. ⟨pasteur-00363393⟩

Collections

PASTEUR
48 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More